While the PD-1/PD-L1 axis remains a cornerstone of immune checkpoint regulation, accumulating evidence highlights the significant contribution of alternative inhibitory pathways in shaping the immunosuppressive TME of NSCLC. The gene discussed is CD274; the disease is non-small cell lung carcinoma.